{"doi":"10.1371/journal.pone.0295651","title":"Elimination of 15N-thymidine after oral administration in human infants","abstract":"BACKGROUND: We have developed a new clinical research approach for the quantification of cellular proliferation in human infants to address unanswered questions about tissue renewal and regeneration. The approach consists of oral 15N-thymidine administration to label cells in S-phase, followed by Multi-isotope Imaging Mass Spectrometry for detection of the incorporated label in cell nuclei. To establish the approach, we performed an observational study to examine uptake and elimination of 15N-thymidine. We compared at-home label administration with in-hospital administration in infants with tetralogy of Fallot, a form of congenital heart disease, and infants with heart failure. METHODS: We examined urine samples from 18 infants who received 15N-thymidine (50 mg/kg body weight) by mouth for five consecutive days. We used Isotope Ratio Mass Spectrometry to determine enrichment of 15N relative to 14N (%) in urine. RESULTS/FINDINGS: 15N-thymidine dose administration produced periodic rises of 15N enrichment in urine. Infants with tetralogy of Fallot had a 3.2-fold increase and infants with heart failure had a 4.3-fold increase in mean peak 15N enrichment over baseline. The mean 15N enrichment was not statistically different between the two patient populations (p = 0.103). The time to peak 15N enrichment in tetralogy of Fallot infants was 6.3 ± 1 hr and in infants with heart failure 7.5 ± 2 hr (mean ± SEM). The duration of significant 15N enrichment after a dose was 18.5 ± 1.7 hr in tetralogy of Fallot and in heart failure 18.2 ± 1.8 hr (mean ± SEM). The time to peak enrichment and duration of enrichment were also not statistically different (p = 0.617 and p = 0.887). CONCLUSIONS: The presented results support two conclusions of significance for future applications: (1) Demonstration that 15N-thymidine label administration at home is equivalent to in-hospital administration. (2) Two different types of heart disease show no differences in 15N-thymidine absorption and elimination. This enables the comparative analysis of cellular proliferation between different types of heart disease.","journal":"PLoS ONE","year":2024,"id":493612,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9559,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":825866,"name":"Jessie Yester","orcid":"0000-0003-2242-1634","position":1,"is_corresponding":false},{"id":895426,"name":"Anita Bargaje","orcid":null,"position":2,"is_corresponding":false},{"id":1340329,"name":"Dawn Thomas","orcid":null,"position":3,"is_corresponding":false},{"id":1340330,"name":"Kathryn C. Little","orcid":null,"position":4,"is_corresponding":false},{"id":1340331,"name":"Shannon Janzef","orcid":null,"position":5,"is_corresponding":false},{"id":1340070,"name":"Kimberly Francis","orcid":"0000-0002-0472-5397","position":6,"is_corresponding":false},{"id":946217,"name":"Jacqueline Weinberg","orcid":"0000-0002-1644-8649","position":7,"is_corresponding":false},{"id":19269,"name":"Jennifer Johnson","orcid":null,"position":8,"is_corresponding":false},{"id":1340332,"name":"Thomas Seery","orcid":null,"position":9,"is_corresponding":false},{"id":734825,"name":"Tyler H. Harris","orcid":"0000-0002-0046-3334","position":10,"is_corresponding":false},{"id":1340333,"name":"Bryan Funari","orcid":null,"position":11,"is_corresponding":false},{"id":1340071,"name":"Kirsten Rose‐Felker","orcid":"0000-0003-3549-2220","position":12,"is_corresponding":false},{"id":1139799,"name":"Matthew Zinn","orcid":"0000-0002-2483-1058","position":13,"is_corresponding":false},{"id":1146600,"name":"Susan A. Miller","orcid":"0000-0001-5870-7867","position":14,"is_corresponding":false},{"id":1340072,"name":"Shawn C. West","orcid":"0000-0002-4369-4394","position":15,"is_corresponding":false},{"id":567446,"name":"Brian Feingold","orcid":"0000-0003-4244-709X","position":16,"is_corresponding":false},{"id":1340334,"name":"Hairu Zhou","orcid":null,"position":17,"is_corresponding":false},{"id":324246,"name":"Matthew L. Steinhauser","orcid":"0000-0001-5287-9246","position":18,"is_corresponding":false},{"id":1340073,"name":"Timothy Csernica","orcid":"0000-0002-5273-0721","position":19,"is_corresponding":false},{"id":1340335,"name":"Robert H. Michener","orcid":null,"position":20,"is_corresponding":false},{"id":283960,"name":"Bernhard Kühn","orcid":"0000-0002-1855-7072","position":21,"is_corresponding":false},{"id":283954,"name":"Niyatie Ammanamanchi","orcid":"0000-0002-9335-3512","position":0,"is_corresponding":true}],"reference_count":22,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T02:09:03.883685Z","pmid":"38271331","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}